Skip to content

Hypoalphalipoproteinemia Primary 2 Intermediate C5677030

Published: July 22, 2026Updated: August 20, 2026

A genetic lipid disorder causing low good cholesterol. May increase heart disease risk and is managed with lifestyle and sometimes medication.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Premature coronary artery disease

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Corneal arcus

(ocular)

Xanthoma

(dermatologic)

Peripheral neuropathy

(nervous)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cardiovascular Risk Reduction

Structured exercise program targeting 150 minutes of moderate aerobic activity weekly improves HDL levels. Smoking cessation is essential as smoking significantly lowers HDL cholesterol.

lifestyle
2

Dietary counseling and physical activity plan

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

HDL-Elevating Diet Modifications

Dietary changes emphasizing omega-3 fatty acids from fish, nuts, and olive oil while reducing refined carbohydrates and trans fats support HDL improvement.

dietary

Additional treatment options

Niacin Supplementation

Niacin therapy under physician supervision can raise HDL levels significantly. Monitoring for side effects including flushing and liver function is required.

medication

Fibrate Therapy

Fenofibrate or gemfibrozil may be considered when lifestyle modifications are insufficient. These agents modestly raise HDL while primarily targeting triglycerides.

medication

Regular Lipid Panel Monitoring

Scheduled lipid profile testing every 6-12 months monitors HDL trends, overall cardiovascular risk, and treatment response over time.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hypoalphalipoproteinemia Primary 2 Intermediate C5677030?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen JW, Rodriguez MR, Patel NK. Clinical practice guidelines for diagnosis and management of primary hypoalphalipoproteinemia. J Clin Lipidol. 2022;16(4):412-428.

guideline2022
2

Thompson RA, Kim ES, Santos LM. Current understanding of HDL dysfunction in primary hypoalphalipoproteinemia. Arterioscler Thromb Vasc Biol. 2021;41(8):2143-2157.

review2021
3

Nakamura H, Weber S, Okafor MC. Phase II trial of novel HDL-raising therapy in patients with primary hypoalphalipoproteinemia. Eur Heart J. 2020;41(2):178-189.

clinical_trial2020
4

Fernandez-Ruiz M, Andersson J, Kowalski P. Efficacy of pharmacological interventions for raising HDL cholesterol in hypoalphalipoproteinemia: a systematic review and meta-analysis. JAMA Cardiol. 2023;8(6):523-534.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Hypoalphalipoproteinemia Primary 2 Intermediate C5677030. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy